Box score
Glyphic Biotechnologies, Inc.
Reported $33.2M sold in a new Form D filed February 16, 2024 (New York, New York).
- Biggest raise
- $33.2M filed Feb 16, 2024
- League
- Bio & Health Biotechnology
- Based in
- New York, New York
- Season rank
- #156 of 1,389 in the Bio & Health League; #604 of 12,443 overall (2024)
- Incorporated
- 2021
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2024-02-16 | New notice | $33.2M | $52.9M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2011516.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Exsilio Therapeutics Inc. rookie | Bio & Health | $38.8M |
| 2 | Grow Care, Inc. | Bio & Health | $35M |
| 3 | Bright Minds Biosciences Inc. | Bio & Health | $34.6M |
| 4 | Atropos Health Inc | Bio & Health | $33M |
| 5 | TMRW Life Sciences, Inc. | Bio & Health | $28.2M |
| 6 | Precision Neuroscience Corp | Bio & Health | $27.5M |